Solventum Corporation (SOLV) Financials

SOLV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2025 14.5 billion 11.3 billion
Dec. 31, 2024 14.5 billion 11.5 billion
Sept. 30, 2024 14.7 billion 11.6 billion
June 30, 2024 14.6 billion 11.7 billion

SOLV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 -80.0 million 49.0 million
Dec. 31, 2024 92.0 million 25.0 million
Sept. 30, 2024 76.0 million 27.0 million
June 30, 2024 297.0 million 56.0 million

SOLV Net Income
Graph available only for supporters. Become a supporter to see it.
DateNet Income
March 31, 2025 137.0 million
Dec. 31, 2024 30.0 million
Sept. 30, 2024 122.0 million
June 30, 2024 89.0 million

SOLV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2025 534.0 million 7.8 billion -
Dec. 31, 2024 762.0 million 7.8 billion -
Sept. 30, 2024 772.0 million 7.8 billion -
June 30, 2024 897.0 million 8.3 billion -

SOLV Shares Outstanding
Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2025 173.0 million
Dec. 31, 2024 174.5 million
Sept. 30, 2024 173.9 million
June 30, 2024 173.5 million

SOLV Expenses
Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2025 109.0 million 193.0 million 769.0 million -
Dec. 31, 2024 127.0 million 199.0 million 784.0 million -
Sept. 30, 2024 93.0 million 189.0 million 701.0 million -
June 30, 2024 58.0 million 192.0 million 701.0 million -

SOLV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2025 2.1 billion 956.0 million
Dec. 31, 2024 2.1 billion 955.0 million
Sept. 30, 2024 2.1 billion 917.0 million
June 30, 2024 2.1 billion 944.0 million

SOLV Revenue by Segment
Graph available only for supporters. Become a supporter to see it.

SOLV

Price: $73.80

52 week price:
47.16
85.92

Earnings Per Share: 2.17 USD

P/E Ratio: 36.18

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Market Capitalization: 13.6 billion

Links: